Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-12-0966
Full Text
Open PDFAbstract
Available in full text
Date
August 19, 2013
Authors
Publisher
American Association for Cancer Research (AACR)